Search

Foster City-based VitaPath Genetics, which is developing molecular diagnostics for detecting Spina Bifida, said today that it has raised $6M in a Series A funding round. The round was led by MDV-Mohr Davidow Ventures, and also included funding from X/Seed Capital. Michael Goldberg of MDV and Michael Borrus of X/Seed are now on the firm's board of directors. VitaPath Genetics said it is developing molecular diagnostics to help correct genetic mutations such as Spina Bifida.
posted on Thursday, September 10, 2009 (Link to more information)

Related companies:
VitaPath Genetics

Related stories:
> Omicia Buys Spiral Genetics
> Crescendo Bioscience Lands $56M
> Myriad Genetics Buys Counsyl For $375M
> 23andMe Uncovers $22M More
> DNA Direct Acquired By Medco Health Solutions

---

silicontap.com Home